多种癌症检测测试的预诊断评估:设计和分析方面的考虑
Stuart G Baker1, Ruth Etzioni2
1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Journal of the National Cancer Institute
|February 29, 2024
概括
一种新的样本大小方法可以显著减少多种癌症早期检测测试所需的参与者数量,提高前诊断研究中积极预测值的准确性.
科学领域:
- 生物统计学 生物统计学
- 在瘤学瘤学.
- 分子诊断学 分子诊断
背景情况:
- 多种癌症检测试验旨在通过基于血液的分子信号来识别临床前癌症.
- 预诊性能的研究对于使用存储样本评估这些测试至关重要.
研究的目的:
- 评估样本大小权衡方法对多种癌症检测测试的诊断前研究的有效性.
- 为了证明样本大小的减少和改进的积极预测值估计.
主要方法:
- 该研究将样本大小权衡方法与诊断前性能研究的标准计算进行了比较.
- 关键指标包括癌症特定的真阳性和假阳性率,以及积极的预测值.
- 样本大小权衡方法优先考虑零假阳性率,而不是精确的真正阳性率目标.
主要成果:
- 样本大小权衡方法大大减少所需的样本大小.
- 对于卵巢癌 (最罕见的病例),它产生了163,000个样本大小,而标准方法的样本大小为720,000个.
- 这种方法增加了积极预测值的下限.
结论:
- 样本大小权衡方法为多种癌症检测测试的诊断前评估提供了更有效的方法.
- 提供了对样本存储库规划和测试评估的建议.
- 这种方法提高了预测性绩效指标的可靠性.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Sensitivity, Specificity, and Predicted Value
329
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
329


